BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12471186)

  • 1. Radiofrequency ablation combined with chemoembolization in hepatocellular carcinoma: treatment response based on tumor size and morphology.
    Yamakado K; Nakatsuka A; Ohmori S; Shiraki K; Nakano T; Ikoma J; Adachi Y; Takeda K
    J Vasc Interv Radiol; 2002 Dec; 13(12):1225-32. PubMed ID: 12471186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-session combined therapy with chemoembolization and radiofrequency ablation in hepatocellular carcinoma less than or equal to 5 cm: a preliminary study.
    Kang SG; Yoon CJ; Jeong SH; Kim JW; Lee SH; Lee KH; Kim YH
    J Vasc Interv Radiol; 2009 Dec; 20(12):1570-7. PubMed ID: 19879777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination therapy with radiofrequency ablation and transcatheter chemoembolization for the treatment of hepatocellular carcinoma: Short-term recurrences and survival.
    Yamakado K; Nakatsuka A; Akeboshi M; Shiraki K; Nakano T; Takeda K
    Oncol Rep; 2004 Jan; 11(1):105-9. PubMed ID: 14654911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggressive Intrasegmental Recurrence of Hepatocellular Carcinoma After Combined Transarterial Chemoembolization and Radiofrequency Ablation.
    Song KD; Lee MW; Rhim H; Kim YS; Kang TW; Shin SW; Cho SK
    AJR Am J Roentgenol; 2016 Nov; 207(5):1122-1127. PubMed ID: 27575338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified cisplatin-based transcatheter arterial chemoembolization for large hepatocellular carcinoma: multivariate analysis of predictive factors for tumor response and survival in a 163-patient cohort.
    Yoon HM; Kim JH; Kim EJ; Gwon DI; Ko GY; Ko HK
    J Vasc Interv Radiol; 2013 Nov; 24(11):1639-46. PubMed ID: 23962438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcatheter arterial chemoembolization combined with radiofrequency ablation delays tumor progression and prolongs overall survival in patients with intermediate (BCLC B) hepatocellular carcinoma.
    Yin X; Zhang L; Wang YH; Zhang BH; Gan YH; Ge NL; Chen Y; Li LX; Ren ZG
    BMC Cancer; 2014 Nov; 14():849. PubMed ID: 25409554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver Resection versus Radiofrequency Ablation plus Transcatheter Arterial Chemoembolization in Cirrhotic Patients with Solitary Large Hepatocellular Carcinoma.
    Saviano A; Iezzi R; Giuliante F; Salvatore L; Mele C; Posa A; Ardito F; De Gaetano AM; Pompili M;
    J Vasc Interv Radiol; 2017 Nov; 28(11):1512-1519. PubMed ID: 28734848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiofrequency ablation combined with chemoembolization for the treatment of hepatocellular carcinomas 5 cm or smaller: risk factors for local tumor progression.
    Takaki H; Yamakado K; Nakatsuka A; Fuke H; Murata K; Shiraki K; Takeda K
    J Vasc Interv Radiol; 2007 Jul; 18(7):856-61. PubMed ID: 17609444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and Efficacy of Transarterial Chemoembolization Combined with CT-Guided Radiofrequency Ablation for Hepatocellular Carcinoma Adjacent to the Hepatic Hilum within Milan Criteria.
    Guo Y; Zhang Y; Huang J; Chen X; Huang W; Shan H; Zhu K
    J Vasc Interv Radiol; 2016 Apr; 27(4):487-95. PubMed ID: 26922006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoembolization Combined with Radiofrequency Ablation for Medium-Sized Hepatocellular Carcinoma: A Propensity-Score Analysis.
    Chu HH; Kim JH; Yoon HK; Ko HK; Gwon DI; Kim PN; Sung KB; Ko GY; Kim SY; Park SH
    J Vasc Interv Radiol; 2019 Oct; 30(10):1533-1543. PubMed ID: 31471190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular carcinoma: long-term results of combined treatment with laser thermal ablation and transcatheter arterial chemoembolization.
    Pacella CM; Bizzarri G; Cecconi P; Caspani B; Magnolfi F; Bianchini A; Anelli V; Pacella S; Rossi Z
    Radiology; 2001 Jun; 219(3):669-78. PubMed ID: 11376253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiofrequency ablation combined with chemoembolization for the treatment of hepatocellular carcinomas larger than 5 cm.
    Takaki H; Yamakado K; Uraki J; Nakatsuka A; Fuke H; Yamamoto N; Shiraki K; Yamada T; Takeda K
    J Vasc Interv Radiol; 2009 Feb; 20(2):217-24. PubMed ID: 19097810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined Therapy with Transarterial Chemoembolization and Radiofrequency Ablation for Hepatocellular Carcinoma: Does the Degree of Ethiodized Oil Accumulation within the Tumor Affect the Therapeutic Efficacy?
    Lee JE; Kim JW; Kim HO; Lee BC; Hur YH; Cho SB; Cho YS; Seon HJ; Kim D
    J Vasc Interv Radiol; 2019 Mar; 30(3):370-379.e4. PubMed ID: 30819479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcome of transcatheter arterial chemoembolization after radiofrequency ablation as a combined therapy for Chinese patients with hepatocellular carcinoma.
    Xu RC; Liu HC; Li JL; Li K; Ou SY; Yu ZY; Kong Y; Ma GA; Shao WS
    Curr Med Res Opin; 2015 Aug; 31(8):1553-60. PubMed ID: 26067770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival with up to 10-year follow-up after combination therapy of chemoembolization and radiofrequency ablation for the treatment of hepatocellular carcinoma: single-center experience.
    Fujimori M; Takaki H; Nakatsuka A; Uraki J; Yamanaka T; Hasegawa T; Shiraki K; Takei Y; Sakuma H; Yamakado K
    J Vasc Interv Radiol; 2013 May; 24(5):655-66. PubMed ID: 23428356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transarterial Chemoembolization versus Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma after Resection within Barcelona Clinic Liver Cancer Stage 0/A: A Retrospective Comparative Study.
    Chen R; Gan Y; Ge N; Chen Y; Wang Y; Zhang B; Wang Y; Ye S; Ren Z
    J Vasc Interv Radiol; 2016 Dec; 27(12):1829-1836. PubMed ID: 27553917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiofrequency ablation combined with chemoembolization: treatment of recurrent hepatocellular carcinomas after hepatectomy.
    Takaki H; Yamakado K; Sakurai H; Nakatsuka A; Shiraki K; Isaji S; Takeda K
    AJR Am J Roentgenol; 2011 Aug; 197(2):488-94. PubMed ID: 21785099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical application of transcatheter arterial chemoembolization combined with synchronous C-arm cone-beam CT guided radiofrequency ablation in treatment of large hepatocellular carcinoma.
    Wang ZJ; Wang MQ; Duan F; Song P; Liu FY; Wang Y; Yan JY; Li K; Yuan K
    Asian Pac J Cancer Prev; 2013; 14(3):1649-54. PubMed ID: 23679250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Transarterial chemoembolization plus computed tomography-guided percutaneous radiofrequency ablation for small hepatocellular carcinoma in special locations].
    Guo YJ; Huang WS; Zhou B; Chen JW; Cai MY; Qian JS; Huang MS; Shan H; Zhu KS
    Zhonghua Yi Xue Za Zhi; 2013 Sep; 93(33):2627-30. PubMed ID: 24360041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma: a randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization.
    Morimoto M; Numata K; Kondou M; Nozaki A; Morita S; Tanaka K
    Cancer; 2010 Dec; 116(23):5452-60. PubMed ID: 20672352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.